Levy, Isra; Coombs, Ann
February 1996
CMAJ: Canadian Medical Association Journal;2/1/1996, Vol. 154 Issue 3, p300
Academic Journal
No abstract available.


Related Articles

  • Mutation Analysis Suggests Role for Ribonuclease L gene in Prostate Cancer. Dunn, F.B. // JNCI: Journal of the National Cancer Institute;2/20/2002, Vol. 94 Issue 4, p244 

    Reports the ribonuclease L gene mutation associated with prostate cancer. Hereditary tendency of prostate cancer; Role of RNASEL gene on chromosome 1 in the development of prostate cancer; Effect of tyrosine kinase on the inflammatory factors.

  • Study Seek to Clarify Genetic Basic of Prostate Cancer in African Americans. Reynolds, Tom // JNCI: Journal of the National Cancer Institute;9/17/2003, Vol. 95 Issue 18, p1356 

    Focuses on the African American Hereditary Prostate Cancer study which will examine the genetic basis of prostate cancer in African Americans. Study background; Recruitment process; Prostate cancer incidence and mortality.

  • Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. Cooney, Kathleen A.; McCarthy, Jenifer D. // JNCI: Journal of the National Cancer Institute;07/02/97, Vol. 89 Issue 13, p955 

    Confirms the presence of prostate cancer locus on chromosome 1q24-25. Method of data collection; Impact of hereditary cancer gene mutations on individual's predisposition to cancer; Role of race on percentage of prostate cancer.

  • New Gene Finding May Yield Clues to Prostate Cancer Complexity. Benowitz, Steve // JNCI: Journal of the National Cancer Institute;03/07/2001, Vol. 93 Issue 5, p344 

    Focuses on genetic studies regarding the complexities surrounding prostate cancer. Evidence of a familial prostate cancer susceptibility gene; Data indicating that mutations to the HPC2 gene on chromosome 17 may be the key to the development of hereditary prostate cancer; Presence of suspect...

  • Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals. Giovannucci, Edward; Rimm, Eric B.; Yan Liu; Leitzmann, Michael; Wu, Kana; Stampfer, Meir J.; Willett, Walter C. // JNCI: Journal of the National Cancer Institute;8/20/2003, Vol. 95 Issue 16, p1240 

    Studies the relationship between the body mass index (BMI) and prostate cancer risk. Complexity of the association due to the dual influence of BMI on hereditary or sporadic cancer; Test qualifications; Revelation of the higher risk of prostate cancer in men with high BMI; Weak association of...

  • Risk of cancer in relatives of prostate cancer probands. Isaacs, Sarah D.; Kiemeney, Lambertus A.L.M // JNCI: Journal of the National Cancer Institute;7/5/95, Vol. 87 Issue 13, p991 

    Determines whether hereditary prostate cancer is associated with cancers at other sites and possibly other heritable cancer syndromes. Case-control families; Multiplex families; Poisson regression analysis of relative risks; Cancer occurrence.

  • 40. Prostate Cancer, Hereditary.  // JNCI: Journal of the National Cancer Institute;2008 Monographs Supplement, Issue 38, p75 

    The article offers information on the disease hereditary prostate cancer. The incidence of HPC is unknown, yet, five to ten percent of prostate cancer patients has a positive family history. The genetic testing for HPC is not available unless the family history is recommending hereditary...

  • Test being developed to tell patients of a hereditary risk of melanoma.  // Dermatology Times;Oct2000, Vol. 21 Issue 10, p35 

    Reports on the development of a test by Myriad Genetics Inc. that will let individuals know if they are at risk of developing hereditary forms of melanoma and prostate cancer. Preventive steps for patients who test positive in the prostate and melanoma susceptibility tests.

  • Knowledge of Hereditary Prostate Cancer Among High-Risk African American Men. Weinrich, Sally; Vijayakumar, Srinivasan; Powell, Isaac J.; Priest, Julie; Hamner, Cathy Atkinson; McCloud, Laryssa; Pettaway, Curtis // Oncology Nursing Forum;Jul2007, Vol. 34 Issue 4, p854 

    Purpose/Objectives: To measure knowledge of hereditary prostate cancer in a group of high-risk African American men. Design: Cross-sectional, correlational pilot study. Setting: Four geographic sites: Detroit, MI; Houston, TX; Chicago, IL; and Columbia, SC. Sample: 79 men enrolled in the African...

  • Prostate-Specific Antigen, Risk Factors, and Prostate Cancer: Confounders Nestled in an Enigma. Thompson, Ian M.; Ankerst, Donna P.; Tangen, Catherine M. // JNCI: Journal of the National Cancer Institute;Sep2010, Vol. 102 Issue 17, p1299 

    The article discusses various issues concerning prostate cancer. It highlights the findings of the Prostate Cancer Prevention Trial (PCPT), which showed the use of biopsy to detect prostate cancer. The risk factors for prostate cancer are discussed, including family medical history, genetics and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics